Phosphorex Names Julia Rashba-Step to Vice President, R&D and Alliance Management
HOPKINTON, Mass., July 10, 2017 — Phosphorex, Inc., a privately held company focused on the development of drug delivery products and technologies, today announced it has named former Pfizer’s Senior Director of Novel Delivery Technologies, Julia Rashba-Step, Ph.D., to the newly created post of Vice President, Research & Development and Alliance Management.
In the role of the head of Novel Delivery Technologies group, Dr. Rashba-Step was responsible for developing the strategy and managing the drug delivery activities for Pfizer’s biologic drug products. The position played a leading role in designing and supporting the biotherapeutics development strategy and was a key driver for the life cycle management process.
Prior to joining Pfizer, Dr. Rashba-Step worked at Epic Therapeutics, a wholly owned subsidiary of Baxter Healthcare Corporation as a Director of Research and Development and later as an Alliance Management Director. In that role, she was responsible for managing all technical and business aspects of collaborations with partners.
Dr. Rashba-Step received her PhD in Biophysics from Russian Academy of Sciences.
Dr. Rashba-Step is a member of multiple professional organizations including serving on the Advisory Board of Drug Delivery Partnerships and mentoring through Healthcare Business Woman Association (HBA).
“Julia’s experience across large pharma and development stage biotech, particularly in drug delivery, means she brings to our company a deep understanding of the opportunities and strategy necessary to build new alliances as well as maintain collaborative relationship with our existing partners,” said Bin Wu, Ph.D., founding President and CEO of Phosphorex, “Julia is ideally suited to help us expand our contract research business in the space of sustained release and targeted drug delivery, and to partner with pharmaceutical companies for the development of new therapeutic products using Phosphorex proprietary delivery platforms and formulation capabilities.”
“This is an exciting time to be working in the field of drug delivery,” said Dr. Rashba-Step. “I am pleased to become part of the Phosphorex team of talented technical experts who are working on cutting edge approaches to delivering innovative therapies to the patients.”
Phosphorex is a worldwide provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug’s release rate, targeting ability, and bioavailability, thereby achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex partners with pharmaceutical companies by supporting all phases of their development, from proof of concept to clinical studies.
For more information, visit www.phosphorex.com
Microspheres, Nanoparticles and Drug Delivery.